Of Escherichia coli and Man: Understanding Glioma Resistance to Temozolomide Therapy
- 20 May 2009
- book chapter
- Published by Springer Nature
- p. 679-711
Abstract
No abstract availableKeywords
This publication has 123 references indexed in Scilit:
- p53 Small-Molecule Inhibitor Enhances Temozolomide Cytotoxic Activity against Intracranial Glioblastoma XenograftsCancer Research, 2008
- Eukaryotic DNA Ligases: Structural and Functional InsightsAnnual Review of Biochemistry, 2008
- Mismatch repair-dependent processing of methylation damage gives rise to persistent single-stranded gaps in newly replicated DNAGenes & Development, 2007
- Homologous recombination prevents methylation-induced toxicity in Escherichia coliNucleic Acids Research, 2006
- Repair deficient mice reveal mABH2 as the primary oxidative demethylase for repairing 1meA and 3meC lesions in DNAThe EMBO Journal, 2006
- The role of autophagy in cancer development and response to therapyNature Reviews Cancer, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- The PARP superfamilyBioEssays, 2004
- DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociationNature, 2003
- CpG Islands in vertebrate genomesJournal of Molecular Biology, 1987